Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go to Privacy Terms.

Tianlong's Presence at Industry Events and Recognitions
Release Date 2023-08-08

At Tianlong, we are always committed to making significant strides in the field of in vitro diagnostics. As a leading in vitro diagnostics company, we continually strive to showcase our range of innovative products and solutions. 

700400.png

Prof. Peng's outstanding contribution award

One of the key highlights that we are extremely proud to share is the recognition received by Professor Niancai Peng, our esteemed founder. His exceptional dedication and contributions to the field of in vitro diagnostics have been acknowledged through the prestigious Outstanding Contribution Award. Bestowed upon him by the government of Xi'an Economic and Technological Development Zone, this award serves as a testament to his invaluable work and expertise.

Tianlong has emerged as a global leader, providing state-of-the-art diagnostic solutions to healthcare professionals worldwide. We are honored to be associated with such a visionary leader whose remarkable achievements continue to inspire us.

官网.jpg

Recap of the 48th CBAC

We would like to take this opportunity to express our heartfelt gratitude to all our friends and supporters who visited Tianlong during the recently concluded 48th Brazilian Society of Clinical Analysis (CBAC). The event provided an ideal platform for us to engage with fellow professionals and discuss the latest advancements in the field of in vitro diagnostics.

During the exhibition, we had the privilege of exchanging ideas, networking, and showcasing our diverse range of products and solutions. Our team was delighted to interact with industry experts and share insights on how our innovative technologies can contribute to improved patient care and disease diagnosis.

The 48th CBAC not only served as a platform for us to strengthen existing partnerships but also enabled us to forge new collaborations. We firmly believe that by working together, we can drive innovation and bring about positive change in the healthcare landscape.


Conclusion

As we continue our journey towards revolutionizing the field of in vitro diagnostics, Tianlong remains dedicated to staying at the forefront of innovation. Our participation in industry events such as the CBAC Exhibition and the recognition received by Professor Niancai Peng are testaments to our commitment to excellence.

We are grateful for the continuous support and encouragement we receive from our valued customers, partners, and industry peers. With their unwavering trust, we are confident in our ability to develop groundbreaking products and solutions that will shape the future of in vitro diagnostics.

Share